Loading...
New criteria for response assessment: role of minimal residual disease in multiple myeloma
Assessment of minimal residual disease (MRD) is becoming standard diagnostic care for potentially curable neoplasms such as acute lymphoblastic leukemia. In multiple myeloma (MM), the majority of patients will inevitably relapse despite achievement of progressively higher complete remission (CR) rat...
Saved in:
| Published in: | Blood |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society of Hematology
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4513329/ https://ncbi.nlm.nih.gov/pubmed/25838346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-11-568907 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|